On May 31, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a new Early Translational…
On May 18, 2018, The Barbara Ann Karmanos Cancer Institute announced it will expand its Lawrence and Idell…
May 4, 2018, scientists from the National Cancer Institute (NCI) reported that an analysis of a prevention clinical…
On Mar. 9, 2018, Seattle Genetics announced it had completed its acquisition of Cascadian Therapeutics for approximately $614…
On Mar. 6, 2018, the U.S. Food and Drug Administration authorized 23andMe’s Personal Genome Service Genetic Health Risk…
In 2018, the University of Michigan Cancer Center was renamed the Rogel Cancer Center in recognition of a…
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…
On Oct. 2, 2017, Emory University was selected by the National Cancer Institute (NCI) for participation in an…
On Aug. 16, 2017, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 60 new academic research,…
On Aug. 15, 2017, the National Institutes of Health’s (NIH) Gabriella Miller Kids First Pediatric Research Program awarded…
On May 10, 2017, Siteman Cancer Center met the standards of the American Society for Radiation Oncology (ASTRO)…
On Mar. 30, 2017, the Fred Hutchinson Cancer Research Center announced that the Bezos family had donated $35…
On Dec. 3, 2016, Celgene, Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences announced the…
On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
On Oct. 18, 2016, the University of Oregon (UO) announced the $1 billion Phil and Penny Knight Campus…
On Sept. 22, 2016, Vanderbilt University Medical Center became the world’s first site to treat a prostate cancer…
On Aug. 15, 2016, Siteman Cancer Center received a $10.4 million five-year grant to Washington University researchers and…
On Jul. 17, 2006, the SERM drug raloxifene (Evista) was found to reduce breast cancer risk for postmenopausal…
On Jul. 5, 2016, The Stanford Cancer Institute announced it had been designated a Comprehensive Cancer Center by…
On Jun. 16, 2016, The University of Michigan Board of Regents announced a $17.5 million commitment for cancer…
On May 19, 2016, President Barack Obama presented Mary-Claire King, Ph.D., a University of Washington professor of medicine…
On May 12, 2016, technology entrepreneur and founder of Oracle, Larry Ellison announced the donation $200 million to…
On Apr. 18, 2016, a team of Oklahoma Medical Research Foundation (OMRF) researchers led by Gary Gorbsky found…
On Feb. 17, 2016, MD Anderson Cancer Center was awarded $14 million from the Cancer Prevention and Research…
On Feb. 17, 2016, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded $26,000,000 in grants to…
On Jan. 12, 2016, a consortium of industry, government, and academia announced the launch of the Cancer MoonShot…
On Jan. 11, 2016, the U.S. Preventive Services Task Force (USPSTF) recommended biennial screening mammography for women aged…
On Apr. 11, 2016, the U.S. Food and Drug Administration (FDA) announced that it had granted accelerated approval…